Evidence map›Paper›PMID 12545154›Full record

ArticleOncogene2003

RhoG regulates gene expression and the actin cytoskeleton in lymphocytes.

Elena Vigorito, Daniel D Billadeu, Doris Savoy, Simon McAdam, Gina Doody, Phillipe Fort, Martin Turner

Abstract read
PubMed Publisher
In one paragraph

Article in Oncogene, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 54 citations in OpenAlex.

  1. Article
  2. Article
  3. Cryo-EM structure revealed a novel F-actin binding motif in abioRxiv : the preprint server for biology · 2025
    Article
  4. Article
  5. Role of RhoG as a regulator of cellular functions: integrating insights on immune cell activation, migration, and functions.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2023
    Review
  6. RhoG's Role in T Cell Activation and Function.Frontiers in immunology · 2022
    Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. NFATc3 contributes to intermittent hypoxia-induced arterial remodeling in mice.American journal of physiology. Heart and circulatory physiology · 2010
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 3 countries.

Elena VigoritoLaboratory for Lymphocyte Signalling and Development, Molecular Immunology Programme, The Babraham Institute, Cambridge, UK. elena.vigorito@bbsrc.ac.uk
Daniel D Billadeu
Doris Savoy
Simon McAdam
Gina Doody
Phillipe Fort
Martin Turner
Babraham Institute · GBMayo Clinic · USCentre de Recherche en Biologie cellulaire de Montpellier · FRSt James's University Hospital · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

RhoG, a member of the Rho family of GTPases, has been implicated as a regulator of the actin cytoskeleton. In this study, we show a novel function for the small GTPase RhoG on the regulation of the interferon-gamma promoter and nuclear factor of activated T cells (NFAT) gene transcription in lymphocytes. Optimal function of RhoG for the expression of these genes requires a calcium signal, normally provided by the antigen receptor. In addition, RhoG potentiation of NFAT requires the indirect activity of Rac and Cdc42; however, pathways distinct from those activated by Rac and Cdc42 mediate RhoG activation of NFAT-dependent transcription. Using effector domain mutants of RhoG we found that its ability to potentiate NFAT-dependent transcription correlates with its capacity to increase actin polymerization, supporting the suggestion that NFAT-dependent transcription is an actin-dependent process. RhoG also promotes T-cell spreading on fibronectin, a property that is independent of its ability to enhance NFAT-dependent transcription. Hence, these results implicate RhoG in leukocyte trafficking and the control of gene expression induced in response to antigen encounter.

Indexed as

Cell Cycle ProteinsNuclear ProteinsActinsB-LymphocytesCalciumcdc42 GTP-Binding ProteinCells, CulturedCytoskeletonDNA-Binding ProteinsFibronectinsGene Expression RegulationGTP PhosphohydrolasesHumansInterferon-gammaJurkat CellsLeukocytesActinsCalciumcdc42 GTP-Binding ProteinCell Cycle ProteinsDNA-Binding ProteinsFibronectinsGTP PhosphohydrolasesInterferon-gammaNFATC Transcription FactorsNuclear ProteinsProto-Oncogene ProteinsProto-Oncogene Proteins c-vavrac1 GTP-Binding ProteinRHOG protein, humanrho GTP-Binding ProteinsTranscription FactorsVAV1 protein, human

Identifiers

PMID12545154
OpenAlexW2010529338

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.